PHG

ACCE-researched
Koninklijke Philips N.V. NY Registry Shares
Healthcare · Medical Devices · NYSE · United States
$24.68+0.00%
Market cap $24.1BNext earnings 2026-11-03Updated Sep 19, 2026
FAIR VALUE · CONSENSUS
$24.68+0.0%
confidence-weighted across 3 of 6 models
Now $24.68
$24.68
$15.31$41.57
HoldBronze46
Price vs fair value
11.3% below
+12.7% to fair value
ACCE score
56
out of 100
Analysts
67% buy
3 covering
P/E
18.8x
forward 12.6x
1-year return
-12.7%
Dividend yield
4.10%
Unlock the ACCE read
INVESTOR

Overview

Reports in 43 days, last quarter beat by 0.4%.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Price

-12.0% · 1Y

Valuation

INVESTOR
Full valuation engine INVESTOR FEATURE

Six independent models converge on one confidence-weighted fair value, with full methodology and editable assumptions.

  • +All six models: DCF, P/E and EV/EBITDA comps, Graham, dividend discount, residual income
  • +Scenario bands, sensitivity tornado, and the 5-year historical valuation range
  • +Editable DCF workbench with saved scenarios

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: conviction breakdown, earnings quality, score history, and backtested returns.

  • +Conviction score breakdown and earnings-quality grade
  • +Growth / value / quality / momentum component scores
  • +90-day score history and score-threshold backtests

Analysts

Wall Street consensus

Bullish67% buy · 3 covering analysts
● Strong buy 1● Buy 1● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO
Smart money tracking PRO FEATURE

Follow the institutions: 13F position changes, insider trades, and active 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Recent open-market insider transactions
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

This stock Peer Peer median weaker → stronger
P/Ebetter than 83% of peers
low 14.8x18.8xhigh 35.3x
ROEbetter than 33% of peers
low 6%10%high 38%
Div yieldbetter than 100% of peers
low 0.0%4.1%high 4.1%

Algorithmic peers (6)

TickerCompanyMcapP/EROED/EYieldQuality
PHIA.ASKoninklijke Philips$24.2B18.910.2%0.624.0%-Compare
4543.TTerumo$20.9B24.310.9%26.361.6%-Compare
GEHCGE HealthCare Technologies Inc. Common Stock $29.0B14.819.4%0.960.2%-Compare
STESTERIS plc (Ireland) Ordinary Shares$20.0B25.111.4%0.271.2%-Compare
ZBHZimmer Biomet Holdings Inc. Common Stock$18.2B23.16.4%0.591.0%-Compare
DXCMDexCom Inc. Common Stock$33.7B35.338.5%0.460.0%-Compare

Sector report card

Where PHG ranks against its sector peers on each metric.

Computing percentiles…

News and Record

Reports in 43 days, last quarter beat by 0.4%.

Press releases mentioning this company

Ask anything, Pro feature

Ask questions about this stock in plain language. Answered from company fundamentals + recent valuations.

PRO

Recent performance

1 week
+0.4%
1 month
-10.6%
3 months
-7.8%
6 months
-6.0%
YTD
-8.9%
1 year
-12.7%

SEC filings

11 filings of 32
July 2026
Jul 28
6-KForeign current reportPeriod 2026-06-30
June 2026
Jun 2
6-KForeign current reportPeriod 2026-06-02
May 2026
May 8
6-KForeign current reportPeriod 2026-05-08
8 more filings + AI summaries on Investor+.INVESTOR